IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re application of:
`
`Euro-Celtique S.A.
`
`Confirmation No.: 1091
`
`Art Unit: 1628
`
`Appl. No.: 14/500,409
`
`Examiner: Ricci, Craig D.
`
`Filed: September 29, 2014
`
`Atty. Docket: 1861.2700001/JMC/MSB
`
`For: Buprenorphine—Wafer for Drug
`Substitution Therapy
`
`Second Supplemental Information Disclosure Statement
`
`Mail Stop Amendment
`
`Commissioner for Patents
`
`PO Box 1450
`
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`Listed on the accompanying form equivalent to form PTO/SB/08b are documents that may
`
`be considered material to the patentability of this application as defined in 37 C.F.R. §1.56. These
`
`documents are being submitted in compliance with the duty of disclosure requirements of 37 C.F.R.
`
`§§ 1.97 and 1.98. The numbering on this Second Supplemental Information Disclosure Statement is
`
`a continuation of the numbering in Applicant's First Supplemental
`
`Information Disclosure
`
`Statement filed on January 21, 2015 in connection with the above-captioned application.
`
`Applicant has listed publication dates on the attached IDS form based on information
`
`presently available to the undersigned. However,
`
`the listed publication dates should not be
`
`construed as an admission that the information was actually published on the date indicated.
`
`Applicant reserves the right to establish the patentability of the claimed invention over any
`
`of the information provided herewith, and/or to prove that this information may not be prior art,
`
`and/or to prove that this information may not be enabling for the teachings purportedly offered.
`
`

`

`- 2 -
`
`Euro-Celtique S.A.
`Appl. No. 14/500,409
`
`This statement should not be construed as a representation that a search has been made, or
`
`that information more material to the examination of the present patent application does not exist.
`
`The Examiner is specifically requested not to rely solely on the material submitted herewith.
`
`This Information Disclosure Statement is being filed before the mailing date of a first Office
`
`Action on the merits. No statement or fee is required.
`
`A copy of document NPL65 is submitted.
`
`It is respectfully requested that the Examiner initial and return a copy of the enclosed IDS
`
`form, and indicate in the official file wrapper of this patent application that the documents have
`
`been considered.
`
`The US. Patent and Trademark Office is hereby authorized to charge any fee deficiency, or
`
`credit any overpayment, to our Deposit Account No. 19-0036.
`
`Date:
`
`February 20, 2015
`
`1100 New York Avenue, NW.
`
`Washington, DC. 20005-3934
`(202) 371-2600
`
`1960193_1
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`/Matthew S. Bodenstein/
`
`Matthew S. Bodenstein
`
`Registration No. 58,885
`
`Atty. Dkt. No. 1861.2700001/JMC/MSB
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket